HORMONES AND BREAST-CANCER

被引：22

作者：

SUNDERLAND, MC

MCGUIRE, WL

机构：

[1] University of Texas Health Science Center, Department of Medical Oncology, San Antonio

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 1991年 / 2卷 / 02期

关键词：

D O I：

10.1016/1043-2760(91)90044-N

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The study of steroid hormone receptors in human breast cancer provides insight into tumor biology and forms the rationale for many therapeutic modalities. Clinical assays for estrogen and progesterone receptors improve the selection of patients who may benefit from hormonal therapy. In addition, receptor content in breast cancer tissue is useful for determining prognosis. Together with other new prognostic factors, hormone receptors help to distinguish among patients with primary breast cancer who are at risk for early recurrence.

引用

收藏

页码：72 / 76

页数：5

相关论文

共 30 条

[1]

ARTEAGA CL, 1989, CANCER RES, V49, P6237

[2] EXPRESSION OF TRANSFORMING GROWTH FACTOR-ALPHA AND ITS MESSENGER RIBONUCLEIC-ACID IN HUMAN-BREAST CANCER - ITS REGULATION BY ESTROGEN AND ITS POSSIBLE FUNCTIONAL-SIGNIFICANCE [J].

BATES, SE ;

DAVIDSON, NE ;

VALVERIUS, EM ;

FRETER, CE ;

DICKSON, RB ;

TAM, JP ;

KUDLOW, JE ;

LIPPMAN, ME ;

SALOMON, DS .

MOLECULAR ENDOCRINOLOGY, 1988, 2 (06) :543-555

[3] CORRELATIONS BETWEEN ESTROGEN-RECEPTOR, PROGESTERONE-RECEPTOR, AND PATIENT CHARACTERISTICS IN HUMAN-BREAST CANCER [J].

CLARK, GM ;

OSBORNE, CK ;

MCGUIRE, WL .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (10) :1102-1109

[4] PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].

CLARK, GM ;

DRESSLER, LG ;

OWENS, MA ;

POUNDS, G ;

OLDAKER, T ;

MCGUIRE, WL .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633

[5] SURVIVAL FROM 1ST RECURRENCE - RELATIVE IMPORTANCE OF PROGNOSTIC FACTORS IN 1,015 BREAST-CANCER PATIENTS [J].

CLARK, GM ;

SLEDGE, GW ;

OSBORNE, CK ;

MCGUIRE, WL .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :55-61

[6] PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER [J].

CLARK, GM ;

MCGUIRE, WL ;

HUBAY, CA ;

PEARSON, OH ;

MARSHALL, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1343-1347

[7]

DRESSLER LG, 1988, CANCER, V61, P420, DOI 10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO

[8]

2-0

[9] EFFECTS OF TAMOXIFEN, TAMOXIFEN METABOLITES, AND NAFOXIDINE ON ADENOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE - CORRELATIONS WITH GROWTH INHIBITORY ACTIVITIES BUT NOT ESTROGEN-RECEPTOR AFFINITIES [J].

FANIDI, A ;

COURIONGUICHARDAZ, C ;

FAYARD, JM ;

PAGEAUX, JF ;

LAUGIER, C .

ENDOCRINOLOGY, 1989, 125 (03) :1187-1193

[10] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484